Specialty Pharmacy Archives

CBD for Pharmacy: Patients, Pets, and Profits

by AlliantRX | Jan 24, 2020 | General Healthcare, Pharmacy Growth, Specialty Pharmacy

CBD for Pharmacy: Patients, Pets, and Profits CBD is everywhere. From gas stations to health food stores, even finding its way into local independent pharmacies. Studies say that by 2024, CBD will be a 20 billion dollar industry. This is a perfect opportunity for...

Purr-fecting Pet Health in Your Pharmacy

by AlliantRX | Jan 14, 2020 | General Healthcare, Social Media, Specialty Pharmacy

Purr-fecting Pet Health in Your Pharmacy You’ve heard the terms – Dog Dad, Cat Mom, Fur Babies – these titles are clear indicators on how much the owner and pet role has changed in your patient’s household. In 2019, Americans spent more than 75 billion on...

NASP: Calling Out DIR Fees and PBM Complicity

by AlliantRX | Sep 28, 2017 | DIR Fees, Independent Pharmacy Insights, PBM, Pharmacy Insights, Specialty Pharmacy

The National Association of Specialty Pharmacy (NASP) made a bold and decisive move by stating its position on specialty drug pricing’s two most controversial issues – DIR Fees and PBM Complicity. The NASP believes that the lack of transparency in assessing these fees...

CBD for Pharmacy: Patients, Pets, and Profits

NASP: Calling Out DIR Fees and PBM Complicity

Recent Posts

Categories

Success!